Assessment of nucleotide/nucleoside analog intervention in primer-dependent viral RNA-dependent RNA polymerases

STAR Protoc. 2022 Jun 21;3(3):101468. doi: 10.1016/j.xpro.2022.101468. eCollection 2022 Sep 16.

Abstract

Nucleotide/nucleoside analogs (NAs) are important compounds used in antiviral drug development. To understand the action mode of NA drugs, we present an enzymology protocol to initially evaluate the intervention mechanism of the NTP forms of NAs on a coronaviral RNA-dependent RNA polymerase (RdRP). We describe the preparation of SARS-CoV-2 RdRP proteins and RNA constructs, followed by a primer-dependent RdRP assay to assess NTP forms of NAs. Two representative NA drugs, sofosbuvir and remdesivir, are used for demonstration of this protocol. For complete details on the use and execution of this protocol, please refer to Wu et al. (2021).

Keywords: Health Sciences; Microbiology; Molecular Biology; Protein Biochemistry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Nucleosides* / analogs & derivatives
  • Nucleosides* / pharmacology
  • Nucleotides* / pharmacology
  • RNA-Dependent RNA Polymerase* / antagonists & inhibitors
  • SARS-CoV-2* / drug effects
  • SARS-CoV-2* / enzymology

Substances

  • Nucleosides
  • Nucleotides
  • RNA-Dependent RNA Polymerase